NCCN Academy

2021-spring-academy-header


NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business

Save the date!
Wednesday, March 30, 2022 | Rosen Shingle Creek in Orlando, Florida
Virtual attendance will also be available!

Overview

During this interactive program, pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Through this pharmaceutical and biotech training program, participants improved their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care spectrum. Pharmaceutical and biotech professionals learned from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

    Please check back often for additional updates regarding this program. If you have any questions, please contact Suzanne Starbuck, Senior Manager, Business Development.

     

    Intended Audience

    Professionals from advocacy, marketing, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

     

    Past Academy Programs

    NCCN Academy occurs biannually during the Spring and Fall. Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.

    For an example program, view the Virtual Academy Program held on June 29, 2020.

    Customize your own NCCN Academy curriculum.

    NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.